ALX Oncology Holdings Inc (NAS:ALXO)
$ 10.61 -0.02 (-0.19%) Market Cap: 552.78 Mil Enterprise Value: 405.05 Mil PE Ratio: 0 PB Ratio: 3.25 GF Score: 34/100

ALX Oncology Holdings Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 01:10PM GMT
Release Date Price: $4.94 (+2.70%)
Li Watsek Cantor Fitzgerald;Analyst

Okay. All right. Good morning, and welcome to our fireside chat with ALX Oncology. I'm Li Watsek, a biotech analyst here at Cantor and very pleased to be joined today by CEO, Jason Lettmann; and CSO, Jaume Pons. Thank you both for being here today.

Jason, nice to meet you in person and congrats on the new role as the CEO. So maybe to level set for our audience, give us a high-level overview, talk about what's coming up and maybe touch on your decision to join ALX now ahead of some pretty big data readout.

Jason Lettmann ALX Oncology Holdings Inc.;CEO

Great. Well, thanks for having us. Appreciate the Cantor team allowing us to talk to you about ALX. We're excited about where we sit. I've joined about three weeks ago, so please direct all the difficult questions to Jaume. But for me, I've been involved in ALX since the earliest days. So helped launch the company back in 2014 out of Stanford and have been on the Board there. So although I'm new very much close to the story and the company over many years.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot